The AAPM Foundation:  Transforming Pain Care Together

Your tax deductible donation helps us transform pain care for our patients, our communities, healthcare in America, and beyond.

 


Enter your donation amount:

$


Donation Frequency

I agree to receive email communication from American Academy of Pain Medicine

Days Left: 26

Announcements


Medicare has released a proposed Local Coverage Determination (LCD) that would eliminate coverage for nearly all peripheral nerve block and related procedures for chronic pain. This proposal represents a significant rollback of access to evidence-based pain management therapies and threatens patients’ ability to receive treatments that help restore mobility, reduce opioid reliance, and improve quality of life. The proposed LCDs cover only radiofrequency neurolysis for trigeminal neuralgia, corticosteroid injections for median neuropathy at the wrist (limited to a maximum of 3 injections), and corticosteroid injections for Morton’s neuroma (limited to a maximum of 2 injections). The AAPM Foundations provides support for evidence-based guidelines that require evidence to advocate for patients' access to main management therapies. Recently, the Foundation has supported work for a Topical Analgesics for Neuropathic Pain Guideline, and we are in the final stages of editing a manuscript for our Restorative Function Guideline. The Academy is partnering with Oregon Health & Science University on an Acute Low Back Pain Guideline funded by the U.S. Food and Drug Administration. Your donations enable AAPM to continue producing evidence-based guidelines that shape your practice and ensure regulatory decisions are based on science. Please donate today. We've raised nearly $250,000 in grants and $11,400 in individual contributions to eliminate pain as a significant public health issue by advancing provider education, supporting groundbreaking research, and ensuring patient access to individualized, comprehensive, and evidence-based pain care.
2025-10-23


May 31, 2024 The American Academy of Pain Medicine Foundation has raised $9,037 from individual contributions to date. Your contributions enable us to make an impact through education and innovative research, continue our advocacy for patient access, and collaborate for a cause. In 2024, we have secured $163,510 in unrestricted grants from Averitas Pharma and Scilex Holdings. These grants will be used to develop a topical analgesic guideline, a project that aims to bolster neuropathic pain management. This project involves a thorough review of existing literature, extensive consultations with experts, and the creation of an evidence-based clinical guideline. Once the guideline is finalized and rigorously validated, it will be submitted to the esteemed Pain Medicine Journal for peer review. Following this, it will be disseminated to clinicians and patients through various channels, and CME education. The ultimate objective of this endeavor is to advance pain management practices and significantly improve patient outcomes, a goal that we believe is crucial and worth every effort.
2024-06-03